Filter
172
Text search:
Prévalence
du
VIH
Featured
Recommendations
10
New Publications
34
Language
Document type
No document type
94
Studies & Reports
35
Guidelines
18
Fact sheets
7
Strategic & Response Plan
6
Manuals
5
Training Material
3
Infographics
2
Resource Platforms
1
Countries / Regions
South Africa
17
Senegal
15
Benin
13
Burkina Faso
6
Congo, Democratic Republic of
5
Central African Republic
5
Cameroon
4
Haiti
4
Rwanda
3
Myanmar / Burma
3
Africa
3
Global
3
Zimbabwe
2
Lesotho
2
South–East Asia Region
2
Latin America and the Carribbean
2
Russia
2
Nigeria
1
Guinea-Bissau
1
Ethiopia
1
Somalia
1
Nepal
1
Kenya
1
Tanzania
1
Cambodia
1
Mozambique
1
Namibia
1
Brazil
1
North Macedonia
1
Ecuador
1
Angola
1
Madagascar
1
Western Pacific Region
1
Western and Central Europe
1
Eastern Europe
1
Armenia
1
Georgia
1
Jamaica
1
Belgium
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
91
Clinical Guidelines
15
Women & Child Health
7
Public Health
2
Key Resources
2
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
HIV
34
TB
27
Mental Health
9
COVID-19
9
Polio
3
NTDs
3
Disability
2
Pharmacy
2
Ebola & Marburg
1
Cholera
1
Refugee
1
AMR
1
Caregiver
1
Health Financing Toolbox
1
NCDs
1
Guía de prácticas esenciales. Segunda edición
Technical Brief
Accessed Sept, 5 2018
Weekly epidemiological record, Relevé épidémiologique hebdomadaire : Vol.93 (2018) No.13
front cover © Jonathan Hyams/Save the Children
The Guide to operationalize HIV viral load testing HIV presents 60 lessons learnt from the project in a systemic approach including: viral load strategy, laboratories, procurement and supply management, patient care and economy.
Offical Statement
INT J TUBERC LUNG DIS 12(12):1376–1379
Evaluation on the Unicef valuation of the UNICEF PMTCT / paediatric HIV care and Treatment programme
Evaluation Report
Evaluation Office
Thirty-three years after its discovery, the Human Immunodeficiency Virus (HIV), responsible for the AIDS pandemic, remains a major public health problem despite advanced researches providing better diagnostic and therapeutic tools. The virus targets especially CD4+ T cells, leading to deficiency of
...
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau
...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud
...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
The National Tuberculosis Programme (NTP) of Rwanda (known as TB & ORD Division/IHDPC/RBC) is preparing to write their next National Strategic Plan and for this reason Rwanda was selected as a country to received technical assistance (TA) to conduct an assessment of their surveillance system using t
...
However, very little is known about the trend of the quality of life over
time in untreated PLWHA compared to treated patients.
Exploring quality of life trends in treated and untreated
patients will help the health care system develop adapted
strategies to better manage the PLWHA in low-income
...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
